Colorectal cancer (CRC) is a leading cause of cancer-related morbidity and mortality worldwide, with early detection and prevention playing critical roles in improving prognosis and survival rates. This study aimed to evaluate the histopathological patterns and clinicopathological characteristics of CRC patients. A cross-sectional observational study was conducted over 12 months at the National Institute of Cancer Research and Hospital (NICRH), Department of Medical Oncology, including 61 diagnosed CRC patients. Ethical considerations were ensured, and written informed consent was obtained. Data were collected and analyzed using SPSS version 22.0. The mean age of patients was 52.18±14.33 years, with a majority over 60 years. A male predominance was observed (60.7% male vs. 39.3% female). The most common clinical features were changes in bowel habits (52.45%), per rectal bleeding (42.62%), and generalized weakness (40.98%). The rectum and anal canal were the most frequent tumor sites (39.3%), followed by the sigmoid colon (31.1%). Morphologically, 40.98% of lesions were ulcerative, 32.78% proliferative, 19.67% infiltrative, and 6.57% ulcero-infiltrative. Histologically, adenocarcinoma was the predominant type (85.2%), followed by mucinous carcinoma (9.8%) and undifferentiated carcinoma (4.9%). Significant differences were noted between asymptomatic and symptomatic patients and between tumor grading in younger versus older patients (p<0.05). Changes in bowel habits, per rectal bleeding, and generalized weakness were the most commonly reported symptoms, with the rectum and anal canal being the most common tumor sites. Adenocarcinoma was the most prevalent histological type, emphasizing the need for early diagnosis and targeted interventions for better outcomes.
Published in | International Journal of Clinical Oncology and Cancer Research (Volume 9, Issue 4) |
DOI | 10.11648/j.ijcocr.20240904.13 |
Page(s) | 63-72 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Colorectal Cancer (CRC), CRC Epidemiology, Clinicopathology, Histopathology, Colonoscopy, and Colon Cancer Prognosis
[1] | Parkin, D. M., Pisani, P., Ferlay, J. Estimates of the worldwide incidence of eighteen major cancers in 1985. International Journal of Cancer. 1993, 54(4), 594–606. |
[2] | Finlay, I., Pickford, I. Colorectal carcinoma. In Lawson, D. H. (Ed.), Current Medicine (4th ed.), Churchill Livingstone, 1994, p. 51. |
[3] |
Cancer Research UK. Bowel cancer statistics 2003. Available from:
https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bowel-cancer . (accessed 9 December 2024). |
[4] | Kolligs, F. T. Diagnostics and epidemiology of colorectal cancer. Visceral Medicine. 2016, 32(3), 158–164. |
[5] | Platz, E. A., Willett, W. C., Colditz, G. A., Rimm, E. B., Spiegelman, D., Giovannucci, E. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes and Control. 2000, 11(7), 579–588. |
[6] | Center, M. M., Jemal, A., Ward, E. International trends in colorectal cancer incidence rates. Cancer Epidemiology Biomarkers and Prevention. 2009, 18(6), 1688–1694. |
[7] | Nguyen, S. P., Bent, S., Chen, Y. H., Terdiman, J. P. Gender as a Risk Factor for Advanced Neoplasia and Colorectal Cancer: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 2009, 7(6), 676–681.e3. |
[8] | Kolligs, F. T., Crispin, A., Munte, A., Wagner, A., Mansmann, U., Göke, B. Risk of advanced colorectal neoplasia according to age and gender. PLoS ONE. 2011, 6(5). |
[9] | Kaminski, M. F., Polkowski, M., Kraszewska, E., Rupinski, M., Butruk, E., Regula, J. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut. 2014, 63(7), 1112–1119. |
[10] | Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., Bray, F. Cancer incidence and mortality worldwide: sources, methods and major patterns in Globocan 2012. International Journal of Cancer. 2015, 136(5), E359–E386. |
[11] | Halder, S. K., Bhattacharjee, P. K., Bhar, P., Pachaury, A., Biswas, R. R., Majhi, T., Pandey, P. Epidemiological, clinico-pathological profile and management of colorectal carcinoma in a tertiary referral center of Eastern India. Journal of Krishna Institute of Medical Sciences University. 2013, 2(1), 45–50. |
[12] | Kaatsch, P., Katalinic, A., Hentschel, S., Luttmann, S., Caspritz, S., Christ, M., Ernst, A., Folkerts, J., Klein, S., Kranzhöfer, K., Kunz, B., Manegold, K., Treml, K., Weg-Remers, S., Baras, N., Barnes, B., Bertz, J., Buttmann-Schweiger, N., Dahm, S., Franke, M., Haberland, J., Kraywinkel, K., Wienecke, A. Krebs in Deutschland 2011/2012. 10th ed. Krebsinformationsdienst des Deutschen Krebsforschungszentrums, 2015. |
[13] | Calva, A. Prostate antigen. A new perception of use in serum. American Journal of Clinical Pathology. 1989, 92(6), 845–846. |
[14] | Dobre, M., Dinu, E., Panaitescu, E., Bîrlă, R., Iosif, C., Boeriu, M., Constantinoiu, S., Ivan, N., Ardeleanu, M., Costache, M. KRAS gene mutations: prognostic factor in colorectal cancer? Romanian Journal of Morphology and Embryology. 2015, 56(2), 671–678. |
[15] | Siegel, R. L., Miller, K. D., Jemal, A. Cancer statistics, 2019 (US statistics). CA: A Cancer Journal for Clinicians. 2019, 69(1), 7–34. |
[16] | Carlos, I., Veintimilla, T. G. R., Rodríguez, Z., Casáus, A. Cancer de colon: Seguimiento posoperatorio. Revista Cubana de Cirugía. 1997, 36(1), 59–63. |
[17] | Kelsen, D., Daly, J., Kern, S., Levin, B., Tepper, J., Van, C. E. Principles and Practice of Gastrointestinal Oncology (2nd ed.). Lippincott Williams and Wilkins, 2008. |
[18] | Silva, A. C., Hara, A. K., Leighton, J. A., Heppell, J. P. CT colonography with intravenous contrast material: Varied appearances of colorectal carcinoma. Radiographics. 2005, 25(5), 1321–1334. |
[19] |
Are, C. Cancer on the Global Stage: Incidence and Cancer-Related Mortality in Bangladesh. Harborside Press, LLC. Available from:
https://www.ascopost.com/issues/february-25-2017/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-bangladesh/ . (accessed 9 December 2024). |
[20] | Li, H., Zhu, F., Boardman, L. A., Wang, L., Oi, N., Liu, K., Li, X., Fu, Y., Limburg, P. J., Bode, A. M., Dong, Z. Aspirin prevents colorectal cancer by normalizing EGFR expression. EBioMedicine. 2015, 2(5), 447–455. |
[21] | Granados-Romero, J. J., Valderrama-Treviño, A. I., Contreras-Flores, E. H., Barrera-Mera, B., Herrera Enríquez, M., Uriarte-Ruíz, K., Ceballos-Villalba, J. C., Estrada-Mata, A. G., Alvarado Rodríguez, C., Arauz-Peña, G. Colorectal cancer: A review. International Journal of Research in Medical Sciences. 2017, 5(11), 4667. |
[22] | Reza, M. M., Blasco, A. J., Andradas, E., Cantero, R., M. J. Systematic review of laparoscopic versus open surgery for colorectal cancer. British Journal of Surgery. 2006, 93, 921–928. |
[23] | Bhat, S. A., Chowdri, N. A., Khan, M. A., Parray, F. Q. Clinicopathological Profile of Colorectal Cancer in Kashmir. Clinics in Surgery. 2019, 4. |
[24] | Sanoff, H. K., Carpenter, W. R., Stürmer, T., Goldberg, R. M., Martin, C. F. Effect of adjuvant chemotherapy on survival of patients with Stage III colon cancer diagnosed after age 75 years. Journal of Clinical Oncology. 2012, 30, 2624–2634. |
[25] | Karim, M. A., Ghosh, A. K., Khatun, R. A., Khatun, J., Chakrabarty, N. Comparative Study of Two Thoracic External Beam Radiotherapy Regimen 30Gy in 10 Fractions Versus 20Gy in 5 Fractions for Palliation of Symptoms in Non-Small Cell Lung Cancer. Radiation Science and Technology. 2024, 10(3), 43–55. |
[26] | Douaiher, J., Ravipati, A., Grams, B., Chowdhury, S., Altaise, O. Colorectal Cancer-global burden, trends and geographical variation. Journal of Surgical Oncology. 2017, 115, 619–630. |
[27] | Benatti, P., Gafà, R., Barana, D., Marino, M., Scarselli, A. Microsatellite instability and colorectal cancer prognosis. Clinical Cancer Research. 2005, 11, 8332–8340. |
[28] | Moghaddam, A. A., Woodward, M., H. R. Obesity and risk of colorectal cancer: A meta-analysis of 31 studies with 70,000 events. Cancer Epidemiology Biomarkers and Prevention. 2007, 16, 2533–2547. |
[29] | Telfah, A., Obeidat, M., AbuKamar, A., Bawaneh, A., Arabeiat, A., AlKafaween, H., Fayyad, L. Clinicopathological characteristics of colorectal cancers at KHMC. Applied Medical Research. 2015, 1(1), 22. |
[30] | Raza, A. M., Kamal, M., Begum, F., Yusuf, M. A., Mohammad, D., Begum, M., Talukder, A. R. Clinicodemographic Characteristics of Colorectal Carcinoma in Bangladeshi Patients. Journal of Current and Advance Medical Research. 2016, 3(1), 22–25. |
[31] | Chakrabarty, N., et al. Chemico-pharmacological screening of the methanol extract of Gynura nepalensis DC deciphered promising antioxidant and hepatoprotective potentials: Evidenced from in vitro, in vivo, and computer-aided studies. Molecules. 2022, 27(11), 3474. |
APA Style
Md., A., Sheherin, T. S., Saikat, B., Kabir, S. M. (2024). Clinicopathological and Histopathological Patterns of Colorectal Cancer: A Cross-Sectional Study at the National Institute of Cancer Research and Hospital. International Journal of Clinical Oncology and Cancer Research, 9(4), 63-72. https://doi.org/10.11648/j.ijcocr.20240904.13
ACS Style
Md., A.; Sheherin, T. S.; Saikat, B.; Kabir, S. M. Clinicopathological and Histopathological Patterns of Colorectal Cancer: A Cross-Sectional Study at the National Institute of Cancer Research and Hospital. Int. J. Clin. Oncol. Cancer Res. 2024, 9(4), 63-72. doi: 10.11648/j.ijcocr.20240904.13
AMA Style
Md. A, Sheherin TS, Saikat B, Kabir SM. Clinicopathological and Histopathological Patterns of Colorectal Cancer: A Cross-Sectional Study at the National Institute of Cancer Research and Hospital. Int J Clin Oncol Cancer Res. 2024;9(4):63-72. doi: 10.11648/j.ijcocr.20240904.13
@article{10.11648/j.ijcocr.20240904.13, author = {Atiquzzaman Md. and Toma Sonia Sheherin and Biswas Saikat and Shahriar Md. Kabir}, title = {Clinicopathological and Histopathological Patterns of Colorectal Cancer: A Cross-Sectional Study at the National Institute of Cancer Research and Hospital }, journal = {International Journal of Clinical Oncology and Cancer Research}, volume = {9}, number = {4}, pages = {63-72}, doi = {10.11648/j.ijcocr.20240904.13}, url = {https://doi.org/10.11648/j.ijcocr.20240904.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcocr.20240904.13}, abstract = {Colorectal cancer (CRC) is a leading cause of cancer-related morbidity and mortality worldwide, with early detection and prevention playing critical roles in improving prognosis and survival rates. This study aimed to evaluate the histopathological patterns and clinicopathological characteristics of CRC patients. A cross-sectional observational study was conducted over 12 months at the National Institute of Cancer Research and Hospital (NICRH), Department of Medical Oncology, including 61 diagnosed CRC patients. Ethical considerations were ensured, and written informed consent was obtained. Data were collected and analyzed using SPSS version 22.0. The mean age of patients was 52.18±14.33 years, with a majority over 60 years. A male predominance was observed (60.7% male vs. 39.3% female). The most common clinical features were changes in bowel habits (52.45%), per rectal bleeding (42.62%), and generalized weakness (40.98%). The rectum and anal canal were the most frequent tumor sites (39.3%), followed by the sigmoid colon (31.1%). Morphologically, 40.98% of lesions were ulcerative, 32.78% proliferative, 19.67% infiltrative, and 6.57% ulcero-infiltrative. Histologically, adenocarcinoma was the predominant type (85.2%), followed by mucinous carcinoma (9.8%) and undifferentiated carcinoma (4.9%). Significant differences were noted between asymptomatic and symptomatic patients and between tumor grading in younger versus older patients (p<0.05). Changes in bowel habits, per rectal bleeding, and generalized weakness were the most commonly reported symptoms, with the rectum and anal canal being the most common tumor sites. Adenocarcinoma was the most prevalent histological type, emphasizing the need for early diagnosis and targeted interventions for better outcomes. }, year = {2024} }
TY - JOUR T1 - Clinicopathological and Histopathological Patterns of Colorectal Cancer: A Cross-Sectional Study at the National Institute of Cancer Research and Hospital AU - Atiquzzaman Md. AU - Toma Sonia Sheherin AU - Biswas Saikat AU - Shahriar Md. Kabir Y1 - 2024/12/31 PY - 2024 N1 - https://doi.org/10.11648/j.ijcocr.20240904.13 DO - 10.11648/j.ijcocr.20240904.13 T2 - International Journal of Clinical Oncology and Cancer Research JF - International Journal of Clinical Oncology and Cancer Research JO - International Journal of Clinical Oncology and Cancer Research SP - 63 EP - 72 PB - Science Publishing Group SN - 2578-9511 UR - https://doi.org/10.11648/j.ijcocr.20240904.13 AB - Colorectal cancer (CRC) is a leading cause of cancer-related morbidity and mortality worldwide, with early detection and prevention playing critical roles in improving prognosis and survival rates. This study aimed to evaluate the histopathological patterns and clinicopathological characteristics of CRC patients. A cross-sectional observational study was conducted over 12 months at the National Institute of Cancer Research and Hospital (NICRH), Department of Medical Oncology, including 61 diagnosed CRC patients. Ethical considerations were ensured, and written informed consent was obtained. Data were collected and analyzed using SPSS version 22.0. The mean age of patients was 52.18±14.33 years, with a majority over 60 years. A male predominance was observed (60.7% male vs. 39.3% female). The most common clinical features were changes in bowel habits (52.45%), per rectal bleeding (42.62%), and generalized weakness (40.98%). The rectum and anal canal were the most frequent tumor sites (39.3%), followed by the sigmoid colon (31.1%). Morphologically, 40.98% of lesions were ulcerative, 32.78% proliferative, 19.67% infiltrative, and 6.57% ulcero-infiltrative. Histologically, adenocarcinoma was the predominant type (85.2%), followed by mucinous carcinoma (9.8%) and undifferentiated carcinoma (4.9%). Significant differences were noted between asymptomatic and symptomatic patients and between tumor grading in younger versus older patients (p<0.05). Changes in bowel habits, per rectal bleeding, and generalized weakness were the most commonly reported symptoms, with the rectum and anal canal being the most common tumor sites. Adenocarcinoma was the most prevalent histological type, emphasizing the need for early diagnosis and targeted interventions for better outcomes. VL - 9 IS - 4 ER -